Thomas Meyer Selected Research

Laparotomy

2/2020	[Successful Biocompatible Treatment of Diaphragmatic Hernia in a Rat Model].
8/2009	Surgical aspects of pneumatosis cystoides intestinalis: two case reports.
2/2009	Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
4/2006	A new biocompatible material (Lyoplant) for the therapy of congenital abdominal wall defects: first experimental results in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Meyer Research Topics

Disease

29	Neoplasms (Cancer) 06/2022 - 01/2002
27	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2024 - 01/2004
13	Infections 10/2020 - 03/2003
10	Disease Progression 01/2022 - 01/2015
9	Neoplasm Metastasis (Metastasis) 06/2022 - 12/2002
7	Inflammation (Inflammations) 04/2024 - 10/2007
7	ST Elevation Myocardial Infarction 01/2023 - 01/2018
6	Wounds and Injuries (Trauma) 08/2023 - 04/2007
6	Skin Neoplasms (Skin Cancer) 01/2023 - 03/2003
6	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 07/2005
6	Tinnitus 01/2019 - 03/2013
6	Chronic Obstructive Pulmonary Disease (COPD) 06/2011 - 01/2007
5	Pain (Aches) 08/2023 - 01/2002
5	Melanoma (Melanoma, Malignant) 01/2023 - 06/2002
5	Heart Failure 01/2020 - 12/2015
5	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2013 - 09/2007
5	Leukemia 08/2009 - 02/2002
4	Basal Cell Carcinoma (Rodent Ulcer) 03/2020 - 11/2002
4	Body Weight (Weight, Body) 02/2020 - 04/2006
4	Sensorineural Hearing Loss 01/2019 - 04/2014
4	Condylomata Acuminata (Genital Wart) 07/2014 - 11/2002
4	Actinic Keratosis 01/2013 - 11/2002
4	Hypoxia (Hypoxemia) 11/2011 - 03/2003
3	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 06/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 05/2010
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2023 - 02/2017
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 03/2003
3	Adenocarcinoma 11/2021 - 01/2015
3	Carcinoma (Carcinomatosis) 08/2021 - 01/2002
3	Coronary Disease (Coronary Heart Disease) 01/2021 - 01/2015
3	Chronic Mucocutaneous Candidiasis 12/2020 - 07/2016
3	Hearing Loss (Hearing Impairment) 10/2018 - 04/2007
3	Colorectal Neoplasms (Colorectal Cancer) 02/2010 - 03/2004
2	Shock 01/2024 - 01/2018
2	Fibrosis (Cirrhosis) 11/2023 - 08/2005
2	Myocardial Infarction 02/2023 - 01/2023
2	Merkel Cell Carcinoma 01/2023 - 05/2021
2	Lymphoma (Lymphomas) 06/2022 - 10/2004
2	Headache (Headaches) 04/2021 - 02/2015
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2021 - 01/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 08/2020 - 10/2018
2	Communicable Diseases (Infectious Diseases) 05/2020 - 09/2014
2	Autoimmune Diseases of the Nervous System 03/2019 - 02/2015
2	Umbilical Hernia (Omphalocele) 02/2019 - 04/2006
2	Heart Diseases (Heart Disease) 01/2019 - 09/2007
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 05/2021 - 04/2007
10	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2004
7	Coe Comfort (FITT)IBA 01/2023 - 01/2018
6	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 03/2003
6	CytokinesIBA 01/2023 - 09/2007
6	STAT1 Transcription FactorIBA 01/2023 - 03/2008
5	AntigensIBA 10/2020 - 12/2007
5	D-JNKI-1IBA 01/2019 - 04/2007
5	Phosphotransferases (Kinase)IBA 04/2007 - 02/2002
4	Transcription Factors (Transcription Factor)IBA 06/2022 - 10/2007
4	LigandsIBA 01/2021 - 10/2007
4	RNA (Ribonucleic Acid)IBA 01/2019 - 03/2003
4	Imiquimod (Aldara)FDA LinkGeneric 06/2012 - 11/2002
4	Tyrosine Kinase InhibitorsIBA 04/2007 - 06/2002
3	Peptides (Polypeptides)IBA 04/2023 - 04/2007
3	Messenger RNA (mRNA)IBA 10/2022 - 01/2019
3	nusinersenIBA 01/2021 - 04/2019
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 07/2004
3	JNK Mitogen-Activated Protein KinasesIBA 01/2019 - 12/2007
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 01/2015
3	rat PDCD5 proteinIBA 01/2017 - 04/2014
3	Glutamic Acid (Glutamate)FDA Link 01/2015 - 03/2003
3	Gemcitabine FDA Link 01/2015 - 12/2004
3	Formoterol Fumarate (Oxis)FDA Link 06/2011 - 01/2007
3	midostaurinIBA 10/2004 - 01/2002
3	Imatinib Mesylate (Gleevec)FDA Link 03/2004 - 02/2002
2	Immunoglobulin G (IgG)IBA 03/2024 - 04/2016
2	Immunoglobulin A (IgA)IBA 03/2024 - 01/2018
2	rasagiline (Azilect)FDA Link 01/2024 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2019
2	LipidsIBA 01/2023 - 01/2019
2	Antisense OligonucleotidesIBA 01/2023 - 01/2023
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 01/2019
2	CholesterolIBA 01/2023 - 01/2019
2	VaccinesIBA 10/2022 - 01/2021
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 06/2022 - 11/2021
2	MicroRNAs (MicroRNA)IBA 08/2021 - 01/2019
2	AntibodiesIBA 03/2019 - 01/2008
2	pro-brain natriuretic peptide (1-76)IBA 01/2019 - 10/2018
2	Natriuretic PeptidesIBA 01/2019 - 10/2018

Therapy/Procedure

26	Therapeutics 01/2024 - 01/2003
8	Drug Therapy (Chemotherapy) 10/2022 - 01/2002
7	Percutaneous Coronary Intervention 02/2023 - 01/2015
5	Neoadjuvant Therapy 11/2021 - 03/2007
4	Transplantation 10/2022 - 03/2003
4	Laparotomy 02/2020 - 04/2006
3	Intratympanic Injection 01/2017 - 03/2013
3	Aftercare (After-Treatment) 06/2012 - 01/2003
3	Dry Powder Inhalers 06/2011 - 10/2007
2	Ambulatory Care (Outpatient Care) 01/2023 - 02/2012
2	Radiotherapy 01/2023 - 02/2011
2	Tracheostomy 01/2023 - 01/2021
2	Patient Readmission 01/2021 - 10/2019
2	Punctures 12/2020 - 01/2014